Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1262
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study ; volume:36 ; number:12 ; day:17 ; month:9 ; year:2021 ; pages:2729-2737 ; date:12.2021
International journal of colorectal disease ; 36, Heft 12 (17.9.2021), 2729-2737, 12.2021
- Creator
-
Smit, Marloes A.
van Pelt, Gabi W.
Terpstra, Valeska
Putter, Hein
Tollenaar, Rob A. E. M.
Mesker, Wilma E.
van Krieken, J. Han J. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00384-021-04023-4
- URN
-
urn:nbn:de:101:1-2022012320015411041967
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smit, Marloes A.
- van Pelt, Gabi W.
- Terpstra, Valeska
- Putter, Hein
- Tollenaar, Rob A. E. M.
- Mesker, Wilma E.
- van Krieken, J. Han J. M.
- SpringerLink (Online service)
Other Objects (12)
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
ISG15 as a prognostic biomarker in solitary fibrous tumour
SOX14 hypermethylation as a tumour biomarker in cervical cancer
Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer
Adult Wilms′ tumour
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
ISG15 as a prognostic biomarker in solitary fibrous tumour
SOX14 hypermethylation as a tumour biomarker in cervical cancer
Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer
Adult Wilms′ tumour
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
Tumour-specific immune responses and tumour stroma analysis in a murine model for pancreatic adenocarcinoma
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
The role of integrins in TGFβ activation in the tumour stroma
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
ISG15 as a prognostic biomarker in solitary fibrous tumour
SOX14 hypermethylation as a tumour biomarker in cervical cancer
Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer